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Freezing processes are a well‐established unit operation in the biopharmaceutical
industry to increase the shelf‐life of protein‐based drugs. While freezing reduces
degradation reaction rates, it may also exert stresses such as freeze concentration.
Macroscopic freeze concentration in large‐scale freezing processes has been de-
scribed thoroughly by examination of frozen bulk material, but the transient process
leading to such freeze concentration profiles has not been monitored yet for bio-
pharmaceutical solutions. In this study, Raman spectroscopy as a process analytical
technology is demonstrated for model formulations containing monoclonal anti-
bodies (mAbs) or bovine serum albumin (BSA) in varying concentrations of sucrose
and buffer salts. Therefore, a Raman probe was immersed into a bulk volume at
different heights, monitoring the freeze concentration in the liquid phase during the
freezing processes. Partial least square regression models were used to quantita-
tively discriminate between the protein and excipients simultaneously. The freeze
concentration profiles were dependend on freezing temperature and formulation
with freeze concentrations up to 2.4‐fold. Convection currents at the bottom of the
freezing container were observed with a maximum height of 1mm. Furthermore,
freeze concentration was correlated with the sucrose concentration in a formulation.
Analysis of the freeze concentration slope indicated diffusion from the bottom to the
top of the container. In summary, Raman spectroscopy is a valuable tool for process
validation of freeze concentration simulations and to overcome scale‐dependent
challenges.
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1 | INTRODUCTION
Pharmaceutical proteins are among the top‐selling drugs with mono-
clonal antibodies (mAbs) as the most successful product (Shukla
et al., 2017). The ever‐growing demand for mAbs leads to the desire
and need for new and larger‐scale manufacturing processes (Buyel
et al., 2017) from which new challenges arise. As the last step, the final
fill, in the production of biopharmaceutical drugs is often located off
the production site, large bulk volumes of formulated drugs need
transportation. To improve the shelf‐life and reduce shear stress
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during transport, bulk substances may be frozen before transportation
(Singh & Nema, 2010). While freezing slows down drug
degradation reactions, it may also induce protein activity loss due to
protein‐ice surface interactions, cold denaturation, and freeze con-
centration gradients (Bhatnagar et al., 2007; Privalov, 1990). There-
fore, drug formulations often contain excipients such as carbohydrates
for protein stabilization in a glassy matrix (Connolly et al., 2015) to
reduce freeze denaturation of proteins. During a freezing process,
freeze concentration occurs, excluding solute molecules from the
crystallizing water. On a microscale, solutes are entrapped within ice
crystals and the amount of water is constantly reduced with
decreasing temperatures until either a glass is formed or solutes start
to crystallize. On a macroscopic scale in large‐scale freezing, freezing
begins at the cooling walls and progresses to the center of the con-
tainer. A transition or mushy zone forms, where ice crystals grow into a
solution. At this mushy freezing front, solutes are partially excluded
and entrapped within the ice matrix. The solute concentration in the
solid phase csolid is reduced compared to the concentration c in the
liquid phase at the freezing front as described by the partition






As a result, solute concentration and temperature gradients are
found in the remaining liquid phase leading to density gradients during
the freezing process. Hence, buoyancy‐driven natural convection occurs
in large‐scale freezing processes. When observing the liquid concentra-
tion c at a fixed point, the relative freeze concentration c/c0, where c0 is
the initial bulk concentration, will increase over time. With increasing
freezing volumes, freeze concentration profiles may change as convection
becomes more dominant (Authelin et al., 2020), which poses scalability
challenges. Natural convection is well described for traditional solidifica-
tion processes such as alloy solidification (Shevchenko et al., 2015;
Vynnycky & Kimura, 2007; Wang & Fautrelle, 2009). However, the
complex solidification of multicomponent solutions frozen in pharma-
ceutical applications currently lacks the process understanding necessary
to overcome scalability issues. In the past, studies have been performed
on novel freeze–thaw devices (Geraldes et al., 2020; Roessl et al., 2014;
Shamlou et al., 2007; Weber & Hubbuch, 2021) with the aim of improved
scalability and processes were mostly characterized by solute con-
centration in the frozen bulk (Kolhe & Badkar, 2011; Miller et al., 2013;
Reinsch et al., 2015; Rodrigues et al., 2012). However, in large‐scale
freezing processes, freeze concentration profiles are a result of the
interplay of diffusive and convective mass fluxes. The analysis of the
frozen bulk concentration lacks information to describe transient mass
fluxes in freezing processes. First, the measured concentrations are
averaged across the sample volume providing a limited spatial resolution.
Second, frozen samples represent the final state with limited information
on the transient freezing process. Recently, computational fluid dynamic
modeling has been proposed as a tool for freeze concentration prediction
(Geraldes et al., 2020; Li & Fan, 2020). While the prediction of tem-
perature has been validated by real‐time process data, the freeze
concentration profiles were only validated by the solute concentration in
the frozen bulk at the end of the process. Online data of freeze con-
centration enables validation of simulated findings with regard to con-
centrations and thus improves model reliability of simulated scale‐up
models. The transient process of freeze concentration was investigated
previously on a microscopic scale by Raman spectroscopy (Dong
et al., 2009) and by Mach–Zehnder optical interferometry (Butler, 2002).
Furthermore, Raman spectroscopy was also suggested as a tool for online
process monitoring of pharmaceutics (Vankeirsbilck et al., 2002). Online
monitoring of the transient, macroscopic freeze concentration is yet
missing. Hence, in the following study, Raman spectroscopy was used for
online monitoring of macroscopic freeze concentration for the first time.
Raman spectroscopy with partial‐least squares (PLS) regression is used for
monitoring individual formulation solutes. The transient, solute‐
dependent freeze concentration effects were analyzed in a large‐scale
freezing process. The study provides an in‐depth process understanding
of diffusive and convective mass fluxes present in freezing processes.
2 | MATERIALS AND METHODS
2.1 | Sample preparation
All used solutions were prepared with ultrapure water (PURELAB
Ultra; ELGA LabWater; Veolia Water Technologies) and filtered using
a 0.2‐µm filter before application. Tris buffer was prepared from Tris‐
(hydroxymethyl)‐aminomethane purchased from Merck and Tris‐
(hydroxymethyl)‐aminomethane‐hydrochloride purchased from
AppliChem at concentrations ranging from 50 to 1500mM. The pH
was adjusted to pH 7.5 ± 0.1 using hydrochloric acid. Sucrose was
used as an exemplary cryoprotectant with low tendency for crystal-
lization (Connolly et al., 2015). Therefore, sucrose with 99% purity
was purchased from former Alfa Aesar now Thermo Fisher Scientific,
and dissolved at concentrations ranging from 250 to 2000mM. All
solutions were prepared from stock solutions. As a model protein,
lyophilized bovine serum albumin (BSA) with a purity exceeding 98%
was purchased from Merck. It was dissolved in the desired buffer
solution at high concentrations using a SpeedMixer DAC 150
(Hauschild) and diluted to the desired concentration. As a typical
pharmaceutical protein, a mAb was kindly provided by Byondis. The
frozen cell culture supernatant was thawed and the mAb was cap-
tured using protein A chromatography. The protein A eluate was
dialyzed against the buffer of interest using 10 kDa Snakeskin
Dialysis Tubing from Thermo Fisher Scientific for 1 h at room tem-
perature and then overnight at 5°C after buffer exchange. The pro-
tein concentration was adjusted using Vivaspin 2 with 30 kDa cut‐off
PES membranes from Sartorius and diluted with buffer.
2.2 | Experimental freezing setup
Bulk freezing was performed in an actively cooled freezing device
depicted in Figure 1. The device is cooled by two individual cooling
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units, one to apply the set freezing temperature and a second one to
cool the bottom of the device to minimize boundary effects such as
freezing from the bottom. The device is split into six individual
chambers to reduce the sample volume by an inlay made from
polytetrafluoroethylene (PTFE). In addition, the inlay insulates the
bottom of a freezing chamber which reduces boundary effects fur-
ther. An in‐depth device and process characterization has been
described previously (Weber & Hubbuch, 2021).
For each experiment, the freezing chamber was filled with 90ml
of process solution. If the samples were reused, the bulk was
homogenized by aspirating and dispensing using a 5‐ml pipette.
Before a freezing process, the temperature was equilibrated for at
least 2 h at 5°C, followed by the initiation of the freezing process at
temperatures between −60°C and −20°C at maximum cooling rate.
After the freezing step, thawing was initiated by a temperature in-
crease to 30°C for mAb and to 40°C for BSA over at least 45min. The
individual steps were timed using predefined methods, which were
executed by in‐house software written with MATLAB 2020b
(MathWorks). The Raman probe and the sample capillary were po-
sitioned at a distance of r = 32mm from the inner cooling wall using
three‐dimensional (3D)‐printed mounts, to assure reproducibility and
precise positioning. The depth of the Raman probe was varied from 1
to 15mm above the bottom of the freezing chamber. The exact
dimensions are noted in Figure 1.
2.3 | Raman spectroscopy
A HyperFlux PRO PLUS 785 from Tornado Spectral Systems with a
bandpass from 200 to 3300 cm−1 from 785 nm wavelength laser at a
power of 495mW together with Fiber BallProbe® from Marqmetrix
was used to obtain Raman resonance spectra. The focal length of the
optics was 200 µm. The spectral resolution was 1 cm−1 and integra-
tion times from 700 to 1400ms were chosen depending on the ex-
posure time suggested by the autoexposure option of the software
SpectralSoft by Tornado Spectral Systems. Spectra were recorded
every 5 s. The laser probe was positioned at a constant distance from
the inner cooling wall, whereas the height above the chamber bottom
was varied from 1 to 15mm as described above.
2.4 | PLS model calibration for online
concentration
PLS models were calibrated from batch experiments spectra ex-
clusively. A set of 55 solutions with varying concentrations of Tris
(0–1000mM), sucrose (0–710mM), mAb (0–25 g/L), and BSA
(0–56 g/L) were prepared from stock solutions. Calibration spectra
were recorded as described above but at room temperature. For each
solution, the probe height and exposure time were varied to account
for possible changes in spectra background, and the spectra were
recorded at least five times. The recorded spectra were processed
using MATLAB R2020b (MathWorks). At least 125 of the total 775
spectra were selected for cross‐validation based on equal solute
concentration distribution across the measured concentrations. For
preprocessing, the spectra were normalized by the exposure time,
smoothed, and optionally derived using a Savitzky–Golay filter with a
second‐order polynomial fit (Savitzky & Golay, 1964). Wavenumbers
below 700 and above 3050 cm−1 were excluded. A background
subtraction using a water or buffer spectrum was evaluated for basic
subtraction and extended multiplicative signal correction (emsc) but
did not improve model accuracy and robustness. For each solute, the
calibrated PLS models were used to calculate concentrations from
the spectra as described by Großhans et al. (2018). Briefly, a Matlab
built‐in genetic algorithm was used to optimize the PLS model based
on calculated predictive residual sum of squares (PRESS) with varying
options such as a number of latent variables (3–10), Savitzky–Golay
smoothing filter window width (5–35), and optional spectrum dif-
ferentiation. Division of the PRESS by the total number of samples
was used for calculation of the root mean square error cross‐
validation (RMSECV). Q2 and R2 were calculated as suggested by
Wold et al. (2001). For modeling of the mAb concentration, spectra
from BSA were excluded and vice versa. Furthermore, high con-
centrations of BSA lead to major changes in the Raman resonance.
Thus, regression of the Tris concentration was performed separately
for samples without and with BSA, where the latter only used in-
formation from 2700 to 3050 cm−1.
2.5 | Offline sample analysis
To validate the PLS predicted concentrations, offline samples of
300 µl were taken at the same radius and height as the Raman probe
using a peek capillary with an inner diameter of 0.17mm and 1‐ml
F IGURE 1 (a) An exploded view of the freeze–thaw scale‐down
model with the insulating inlay. The bottom temperature is controlled
separately to reduce boundary effects. The freezing chamber is
separated by an inlay into six chambers. A cross‐section through one
chamber as highlighted by the dashed box is shown in (b). The Raman
probe and capillary for sampling are depicted in gray and green,
respectively. Images were adapted fromWeber and Hubbuch (2021).
PTFE, polytetrafluoroethylene
WEBER AND HUBBUCH | 3
syringes. The protein concentration of the samples was measured by
UV‐absorption at 280 nm using a NanoDrop 2000c by Thermo Fisher
Scientific. Extinction coefficients of 0.67 g/(L cm) for BSA and
1.5 g/(L cm) for mAb have been used. To determine sucrose and Tris
concentrations, the conductivity and density of samples were mea-
sured using a conductivity meter CDM230 (Radiometer Analytical
SAS) and microliquid density sensor (Integrated Sensing Systems, Inc).
As both solutes affect both density and conductivity, a 2D regression
calibration was performed with 32 samples ranging from 0 to
300mM Tris and 0 to 1200mM sucrose. The calibration results were
approximated by second‐order polynomial regression resulting in an
R2 of 0.999 for the conductivity and 0.999 for the density. Detailed
calibration information is listed in the Supporting Information
Material.
3 | RESULTS AND DISCUSSION
3.1 | Liquid freeze concentration monitoring with
Raman spectroscopy
The freezing process of pharmaceutical formulations was evaluated
using Raman resonance spectroscopy. Spectral changes over the
course of a freezing process may occur due to for example tem-
perature deviation presented and discussed in the following. The
Raman spectrum of a purified water sample measured in the freezing
chamber at room temperature contained peaks at 1637 and
3235 cm−1 attributed to water and peaks at 732, 1215, 1300, and
1380 that occur due to the PTFE (Schmälzlin et al., 2014) bottom of
the freezing chamber. The transition from water to ice can be
observed in the spectra at 3140 cm−1, where a distinct ice peak
arises, while the water peak at 3235 cm−1 declines as the solution
freezes as shown in Figure 2b. The ice peak was described and
compared already in the early 1930s by Ockman (1958) and the
transition during solidification was recently used to describe phase
transition from water to ice (Ðuričković et al., 2011). In addition,
baseline shifts were present throughout all measurements, which are
comparable to Raman spectra of biological samples (Guo et al., 2016)
in the fingerprint region from 700 to 1900 cm−1 and due to the broad
water resonance peak from 2600 to 3330 cm−1. The addition of so-
lutes leads to numerous peaks in the fingerprint region and from
2600 to 3050 cm−1, as well as baseline shift changes in the finger-
print region. The spectra observed at 5 mm above the bottom for a
model formulation with 50mM Tris and 200mM sucrose frozen at
−20°C is depicted in Figure 2.
As shown in Figure 2a, the spectra remain stable until around
30min when freezing at −20°C. After 30min, most of the peaks in
the fingerprint region began to increase due to freeze concentration.
Water peaks, however, remained constant until solidification began.
When the freezing front reached the Raman probe, ice crystals are
formed leading to a significant decrease of the mean Raman
resonance as shown in Figure 2c. The decrease of the mean spectrum
can be attributed to changes in optical density due to crystallization.
Thus, the rapid decrease in the mean spectra was used to detect the
beginning of the phase change. Ðuričković et al. (2011) suggested
using a ratio SD of water and ice peak areas to describe the phase
transition. Similarly, SD was calculated after Equation (2) by summing
up the raw Raman intensities I for the water peak area from 3270 to
3290 cm−1 and the ice area from 3140 to 3160 cm−1. When com-
paring the mean Raman resonance and SD, as shown in Figure 2c,
both signals decreased upon arrival of the freezing front at the
Raman probe after 44min. The mean Raman signal decreased rapidly
and stabilized after 60min total, whereas SD decreased later and
continuously decreases over the observed time. This indicates, that
the majority of solidification has taken place after 16min and optical
properties reached an equilibrium. Meanwhile, the water crystals are
continuously formed and the ice structure changes as seen in SD,
while the solution is approaching phase equilibrium given for the
F IGURE 2 (a) Example Raman spectra over time when freezing a 50mM Tris, 200mM sucrose solution at −20°C. Probe height was 5mm.
(b) Raman spectra shift from water to ice used for calculation of SD. (c) Comparison of the mean spectrum and the water to ice peak areas SD
over time.
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current temperature. Ideally, the method would be able to predict the
solute concentration in the frozen state. However, PLS modeling of
freeze concentrated solution would require frozen solutes with
known concentration for model calibration. Due to microscale freeze
concentration within the crystalline ice structure, this was not pos-
sible with the used set‐up. Twomey et al. overcame this issue by the
implementation of confocal Raman spectroscopy (Twomey
et al., 2015). In this study, the application of PLS models derived from
liquid samples on frozen state, however, resulted in large differences
for Tris and sucrose as shown below in Section 3.3, and predicted
concentrations postfreezing were not reproducible. The Raman
probe and laser introduce heat in the system, influencing the ice
structure and glass composition. Thus, the predictions of con-
centration are only valid in the liquid state and the freeze con-













3.2 | PLS modeling of Raman spectra for
concentration quantification
PLS models were used to quantify and distinguish up to three
individual formulation agents. PLS regression coefficient of each so-
lute is shown in Figure 3 and the PLS modeling characteristics are
summarized in Table 1.
For all solutes except BSA, the first derivative of the spectra led
to the best modeling results. While one PLS model for sucrose
quantification could be used for all samples, a separate model for Tris
quantification was used for samples containing BSA, where only the
wavenumbers from 2700 to 3050 cm−1 were used. In general, three
to nine latent variables have been used with a Savitzky–Golay filter
window between 5 and 19 wavenumbers. Other studies used five to
seven latent variables (Filik & Stone, 2007; Parachalil et al., 2018) for
the prediction of protein concentrations with Raman spectroscopy.
The calculated coefficients of determination R2 ranged from 0.997 to
0.999 with similar Q2 values. The models provided a good linear
correlation across all the calibration concentrations. Despite the
promising quality attributes of the models, the model data was
generated solely from batch measurements at room temperature.
Temperature changes and convection in the freezing process might
cause background variations and noise reducing model accuracy.
Therefore, validation of the predictions in freezing processes was
performed to evaluate deviations from batch measurements as
discussed later. Spectral preprocessing to minimize the influence of
process conditions on the model was evaluated by emsc and sub-
traction of a water spectrum as a background. However, this intense
preprocessing did not improve the model by means of R2 and pre-
dicted high noise levels when applied to freeze process data. Fur-
thermore, spectrum normalization, while giving the opportunity of
overcoming challenges in optical property shift, also led to worse R2
values and high signal‐to‐noise ratios in the predicted concentrations
in the process.
3.3 | Validation of Raman concentration
monitoring
To validate PLS predicted freeze concentration, the predicted con-
centrations were compared against concentrations in liquid samples,
that were aspirated at a 5 min interval using a capillary. The Raman
probe and capillary were positioned 5mm above the chamber bottom
at an equal distance from the inner freezing wall, as indicated in
Figure 1b. Two studies with and without protein were performed.
First, a 200mM sucrose, 100mM Tris solution at pH 7.5 was frozen
at −20°C, and concentrations measured and predicted are shown in
Figure 4.
Between 5 and 30min, the solute concentration remained stable
with offline concentrations of 106 ± 1.2 mM Tris and 197 ± 2.5 mM
sucrose and online predicted concentrations of 112 ± 3.6mM Tris
and 203 ± 3.0 mM sucrose. The agreeing measurements and the low
signal variation highlight the PLS model accuracy and the robustness
with regard to noise. After 30min, the solute concentration of Tris
and sucrose increased in both online and offline measurements.
While offline measurements showed maximum concentrations of
189mM Tris and 338mM sucrose after 50min, the Raman spectra
indicated concentrations of 171mM Tris and 315mM sucrose. The
differences may be attributed to continuous extraction of con-
centrated samples at the capillary thus adding a source of turbulence
and mixing. As a result of the mixing, the higher concentrated solu-
tion might be aspirated from the lower layers, as shown later. After
F IGURE 3 Normalized partial least square regression coefficients
for the prediction of solute concentration. The regression coefficients
of the solute are highlighted as a bold line, while the remaining
coefficients are supplemented in gray. Bovine serum albumin (BSA)
spectra are nonderived. Monoclonal antibody (mAb), Tris, and
sucrose coefficients are applied to the first derivative of a spectrum
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50min, the freezing front reached both the Raman probe and the
capillary leading to an apparent decrease in online predicted con-
centration. The offline measurements, on the other hand, indicated a
steep increase in concentration. While the arrival of the freezing
front was clearly detected by Raman spectroscopy, liquid sampling
was still possible. The offline measurements did no longer measure
the bulk concentration but instead, the freeze concentrated liquid
extracted through the capillary. Furthermore, the end of the capillary
was located approximately 7mm away from the Raman probe focal
point. Due to the thermal impact of the Raman probe, freeze con-
centration might have been impacted by the probe itself.
When examining the freeze concentration of a highly con-
centrated BSA solution with 56 g/L BSA, 100mM Tris, and 225mM
sucrose at pH 7.5, similar results were found, as shown in Figure 5.
From 0 to 30min, 59.3 ± 1.1 g/L BSA, 99.4 ± 8.6 mM Tris, and
222.9 ± 2.3 mM sucrose were predicted and 56 ± 0.4 g/L BSA were
measured offline. In general, the predicted concentrations show an
offset to the initial concentration of 3 g/L. Adding BSA to the for-
mulation significantly decreased the PLS model robustness of Tris, as
standard deviations of up to 9% were observed over the first 25min
compared to 3% without BSA. Looking at the relative freeze con-
centration (c/c0) shown in Figure 5b, the BSA concentration
increased by 38% detected by Raman and by 37% measured offline
after 57min (offline increase interpolated linearly). The root mean
square error of prediction (RMSEP) between measured and predicted
BSA concentrations was 3.8 g/L absolute and 1.5% for relative con-
centrations. In comparison, Parachalil et al. (2018) reported an
RMSECV of 1.58 g/L for albumin quantification by Raman spectro-
scopy from 5 to 50 g/L and Filik and Stone (2007) reported RMSEPs
of 8%–11% of the mean concentration, which is in range with our
model. Other models report lower RMSEPs around 1mM for glucose
(Rohleder et al., 2005), but have a smaller upper calibration limit of
24mM. The presented model focuses on the determination of the
relative freeze concentration rather than the exact quantification of
solutes.
3.4 | Freeze concentration at different
temperatures
A highly concentrated BSA solution of 50 g/L BSA, 50mM Tris,
225mM sucrose at pH 7.5 was frozen at different temperatures and
monitored with the Raman probe 5mm above the ground. The
influence of the freezing temperature on the freeze concentration
TABLE 1 Summary of the Raman
spectrum preprocessing parameters, the
PLS model parameters, and the quality of
prediction for each solute
mAb sucrose Tris BSA Tris (with BSA)
Latent variables 8 7 5 9 3
Savitzky–Golay
window
11 29 19 15 5
Derivative 1 1 1 0 1
Wavenumbers /cm−1 700–3050 700–3050 700–3050 700–3050 2700–3050
R2 0.998 0.997 0.999 0.999 0.939
Q2 0.999 0.999 1.000 1.000 0.999
RMSECV 0.07 g/L 1.08mM 0.72mM 0.08 g/L 2.56mM
Calibration range 1.7–25 g/L 80–708mM 31–1000mM 14–56 g/L 31–1000mM
Note: Two Tris models were used for prediction in the presence and without BSA.
Abbreviations: BSA, bovine serum albumin; mAb, monoclonal antibody; PLS, partial least square; Q2,
cross‐validated R2; R2, coefficient of determination; RMSECV, root mean square error cross‐validation.
F IGURE 4 Freeze concentration predictions online with Raman
and offline by sampling at a 5‐min interval. The Raman probe was
positioned 5mm above ground. Tris and sucrose determination by
conductivity and density
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profile was investigated. Within the first 5min of all freezing ex-
periments shown in Figures 6 and 7, concentrations of 51 ± 0.6 g/L
BSA, 32 ± 2.2 mM Tris, and 235 ± 3.2 mM sucrose were predicted. As
starting concentrations c0 remain the same across the experiments,
only relative concentrations (c/c0) of BSA and sucrose are described
and discussed in the following.
As expected, the freezing time was reduced with decreasing
freezing temperatures. In addition, freeze concentration was not
observed when freezing at −40°C or below. For higher freezing
temperatures, the freeze concentration at the time of freezing
increases with temperature. The correlation of freezing time t to the
negative inverse of cooling temperature Tcooling (t∼ −1/Tcooling) as
well as similar freeze concentration behavior in frozen bulk media
was shown previously (Weber & Hubbuch, 2021).
Looking at the freeze concentration of BSA, the concentration
began to increase later than the sucrose concentration after
35–40min and quickly exceeded the sucrose concentration. The
maximum relative concentration difference between BSA and su-
crose (cBSA/cBSA,0 − csucrose/csucrose,0) occurring at −20°C was 11.8%
after 51min and narrowed down over time to 3.1% after 58min.
Interestingly, the freeze concentration showed a similar pro-
gression over time throughout all examined freezing temperatures.
For example, the relative sucrose concentration exceeds the BSA
freeze concentration for all experiments between 20 and 30min.
More specifically, the relative sucrose concentration increased by
1.4 ± 0.25% after 35min across freezing temperatures from −20°C to
−30°C and after 40min by 4.6 ± 0.87% across freezing temperatures
from −20°C to −25°C. This indicates, that freeze concentration and
thus the partition coefficient in larger pharmaceutical tanks might be
primarily dependent on freezing time. Natural convection can explain
this phenomenon as illustrated in Figure 8.
The freezing time correlates with the freeze front velocity, which
increased with lower freezing temperatures in this study. However,
the freeze concentration was similar over time at different freezing
temperatures and thus independent from the freeze front velocity. If
the natural convection was negligible, the concentration profile at the
freezing front would be dominated by diffusion forming a diffusive
concentration layer. This diffusive layer would lead to a similar freeze
concentration at the end of each freezing process across varying
temperatures when the layer reaches the Raman probe. In this study,
however, the opposite was found. Convection dominated the freez-
ing processes dragging the concentrated solutes from the freezing
F IGURE 5 Freeze concentration predicted online with Raman and measured offline by sampling at a 5min interval. The Raman probe was
positioned 5mm above ground. Bovine serum albumin (BSA) concentration determined by UV–Vis absorption at 280 nm. (a) Absolute
concentrations. (b) Concentrations normalized by initial values
F IGURE 6 Sucrose (‐) and Bovine serum albumin (BSA) (‐‐)
relative freeze concentration at different freezing temperatures. The
Raman probe was positioned 5mm above ground. Concentrations
are shifted by 0.05 for visualization purposes. Outliers at −30°C were
excluded
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front along the bottom to the center and thus reducing the formation
of a diffusive layer. Low convection current flow rates are expected
at the freezing front and the container bottom. Hence, the current at
the bottom needs time to reach the Raman probe. For shorter
freezing times at low freezing temperatures faster freeze front
velocities will occur. The convective current at the bottom might be
slower and thus freeze concentrated solution is entrapped. Hence,
similar freeze concentration profiles independent from the freezing
temperature indicate convective flow. In addition, similar freeze
concentration profiles indicate a constant partition coefficient
independent of the freezing temperature. Butler (2002) evaluated the
freeze concentration in smaller thin films without convection and
found a constant partition coefficient. It was used to describe freeze
concentration by a quasi‐steady‐state approximation valid for low
molecular weight solutes and at slow freezing speeds.
3.5 | Freeze concentration at different heights
As indicated in Figure 8, natural convection drags freeze con-
centrated solution to the bottom of a container, and freeze
concentration‐time profiles will change along a vertical axis. There-
fore, the model solution, containing 50 g/L BSA, 50mM Tris, and
225mM Sucrose at pH 7.5, was frozen at −20°C and monitored at
different heights from 1 to 15mm above the ground. The relative
freeze concentration behavior of BSA and sucrose at the different
levels is depicted in Figure 7a.
The relative freeze concentration was detected first at the bot-
tom of the container and continuously progressed throughout the
different layers. More specifically, the sucrose freeze concentration
exceeded 101% after 19, 30, 33, 35, 37, and after 45min at heights
of 1, 2.5, 4, 5, 6, and 7.5mm, respectively. The freeze concentration
of BSA was detected before sucrose at the bottom of the container
but was delayed at elevated heights. The relative freeze concentra-
tion of BSA exceeded 101% after 13, 31, 35, 38, 43, and 52min at
heights of 1, 2.5, 4, 5, 6, and 7.5mm, respectively.
As freezing continued, the freeze concentration of sucrose in-
creased exponentially at the beginning and turned into a linear,
steady concentration increase. The maximum relative freeze con-
centration 1mm above ground was 2.42‐fold for BSA and 2.38‐fold
for sucrose. It decreased rapidly over height to a 1.42‐fold BSA and
1.38‐fold sucrose freeze concentration at 5 mm. Other studies eval-
uated the freeze concentration in a frozen cylindrical vessel by slicing
the frozen bulk in 7mm thick layers and found a twofold to threefold
F IGURE 7 Freeze concentration of bovine serum albumin (BSA) formulation at different heights. (a) freeze concentration at −20°C of
BSA (‐‐) and sucrose (‐). (b) freeze concentration at −20°C of BSA relative to sucrose over time for different heights h. The color scheme in
(a) and (b) is the same. Lines are shifted by increments of 0.03 for visualization purposes. (c) final freeze concentration slope of sucrose before
freezing as indicated by solid black lines in (a)
F IGURE 8 Schematic of a freeze concentration profile. The
freezing front moves from the left, cooling wall towards the center.
Liquid currents are displayed by arrows, where the velocity is
represented by arrow length. Diffusion occurs orthogonal to
isoconcentration lines. Convective mass transport drags solute
enriched liquid along the bottom of the chamber from where it
diffuses to the top
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increase of BSA and trehalose (Rodrigues et al., 2011). Roessl et al.
(2014) found freeze concentrations of up to 2.5‐fold for lactic de-
hydrogenase and phosphate for frozen sampling over 14mm sample
height. While the results from this study are within the range of the
previously described freeze concentrations, they indicate that the
freeze concentration measured by frozen sampling may under-
estimate the maximum freeze concentration by up to onefold as it
evaluates the average freeze concentration over a sample height.
The ratio of BSA to sucrose concentration is shown in Figure 7b.
When comparing the freeze concentration of BSA to the freeze
concentration of sucrose, it appears, that an initial peak of BSA was
transported from the bottom to the top of the freezing chamber.
Right before freezing, the ratio of BSA to sucrose concentration
((cBSA,end/cBSA,0)/(csucrose,end/csucrose,0)) was similar across all heights
with 1.01 ± 0.02‐fold. As these results are the first description of
online monitored freeze concentration, the following hypothesis is
derived. The maximum natural convection occurs at the beginning of
freezing processes (Geraldes et al., 2020), as the highest density
gradients are formed due to the initial large temperature differences
in the bulk medium. Higher concentrations of BSA compared to su-
crose might be dragged to the bottom of the container. Two potential
reasons are a smaller partition coefficient leading to higher exclusion
from the freezing front and/or slower diffusion of the larger molecule
(Torres et al., 2012). The current velocity at the freezing front de-
clines over the distance from the freezing front as shown in Figure 8.
With increasing diffusion coefficients, molecules diffuse further into
the convective current due to the orthogonality of the concentration
gradient and the convection current. Thus, the freeze concentration
at the bottom is a complex interplay between diffusive and con-
vective mass transport at the freezing front. With comparably slow
diffusion, BSA might initially not be able to escape the convection
flux in contrast to the smaller sucrose molecules. Over time, BSA is
dragged to the container bottom by convection. From there it dif-
fuses vertically to the top of the container as the concentration at the
bottom continuously increases by convection. This may lead to an
initial BSA‐rich concentration peak first detected at the bottom.
Under the assumption of the negligible contribution of convective
mass transport along the observed vertical axis, the data can be used to
evaluate the impact of the diffusive flux according to Fick's second law,
which describes diffusion over time driven by spatial concentration dif-
ferences (Fick, 1855). However, due to the necessity of second‐order
derivation in space, a low number of selected spatial measurements are
not sufficient to provide a reliable dataset. An external long‐distance focal
point Raman probe could be used for spatially resolved datasets to
overcome this issue. In this study, however, mass fluxes can only be
interpreted on a qualitative scale. Thus, the slopes of the sucrose freeze
concentration over time right before freezing have been fitted, as
indicated in Figure 7a, and are shown in Figure 7c for temperatures of
−20°C and −30°C. From the bottom of the freezing chamber, where the
concentration is continuously increased by convection, the concentration
slope declines until approximately 7.5mm above ground, where stagnant
slopes were present. The continuously decreasing slopes over the height
indicate the degree of diffusion and support the hypothesis of diffusion
from the bottom to the top of the container. In addition, the decreasing
slopes over height, as well as steadily increasing concentrations, imply low
turbulences in the freezing process and thus laminar flow. On the other
hand, the stagnant slopes in higher layers indicate a diffusion layer in front
of the mushy freezing zone that has formed over time. The diffusive layer
at the freezing front reaches the Raman probe at a similar time across the
entire height, explaining the similar degree of freeze concentration found
at elevated heights. Exemplarily measured freeze concentration at −30°C
at three heights showed reduced freeze concentration slope without
hardly any detected diffusion layer as shown by the slopes in Figure 7c.
Finally, with increasing distance between probe and chamber
ground, the freezing time increased. This can be attributed to the
impact of the stainless‐steel probe due to heat conduction of the
room temperature through the insulation into the freezing chamber.
For further studies, this might be avoided by the use of an external
Raman probe with a long focal distance.
3.6 | Formulation dependent freeze concentration
Lastly, the influence of solute concentration on the freeze con-
centration behavior was investigated for common industrial for-
mulation components. An industrial formulation was mimicked by a
mAb formulated in Tris and varying concentrations of stabilizing
sucrose. The solutions were frozen at −20°C and the freeze con-
centration was monitored at a height of 5 mm. The freeze con-
centration profiles are depicted in Figure 9.
The formulations contained 4 g/L mAb, 50 mM Tris, and
100–300 mM sucrose at pH 7.5. The initially predicted con-
centrations were 3.9 ± 0.14 g/L mAb, 49.6 ± 2.3 mM Tris, and
105, 159, 211, 289 mM sucrose for the individual formulations.
This indicates the model accuracy and in the following, only the
relative freeze concentration (c/c0) will be described. In general,
the maximum freeze concentration of mAb increased with su-
crose concentration. Maximum freeze concentrations of 1.28‐
fold mAb, 1.33‐fold Tris, and 1.37‐fold sucrose were observed
right before freezing. Similar to the BSA case study, low mole-
cular solutes were concentrated to a similar degree. The mAb,
however, was the least freeze concentrated for all formulations.
As mAb with approximately 150 kDa is larger than BSA with
66 kDa, it has a lower diffusion coefficient (Torres et al., 2012).
Diffusion towards the center reduces the concentration at the
freezing front. As shown in Equation (1), the amount of solute
encapsulated at the freezing front is dependent on the solute
concentration at the freezing front. Thus, larger proteins may
experience overall less freeze concentration as they are en-
trapped by the freezing front to a higher degree, which agrees
with the freeze concentration of different proteins in the cell
culture supernatant (Weber et al., 2021). Kolhe and Badkar
(2011) also reported significant differences in sugar and mAb
freeze concentration for solutions frozen in bottles. However, the
diffusion of the proteins in the two cases is also dependent on the
viscosity, which is different for the BSA and mAb formulation.
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In addition to that, the final slope of freeze concentration before
freezing increased with sucrose concentration for both mAb and
sucrose as shown in Figure 10. The outlier of mAb freeze con-
centration at 100mM sucrose can be attributed to the comparably
high noise of the prediction.
Next to higher overall freeze concentration, high sucrose con-
centrations also led to earlier detection of freeze concentration.
Under the assumption of a similar partition coefficient for the given
concentrations, more molecules are excluded from the ice matrix
upon freezing with increasing concentrations resulting in higher
absolute concentration gradients in the liquid phase. Because the
measured buffer density is proportional to the sucrose concentration,
higher density gradients in the bulk solution will occur leading to
increased convection. In contrast to the BSA freeze concentration,
freeze concentration of mAb and sucrose occurred at approximately
the same time despite different diffusion coefficients, suggesting that
the initial freeze concentration is dominated by convection for for-
mulations with low concentrations of mAb. Furthermore, the visc-
osity also increases with the sucrose concentration, which reduces
diffusive and convective mass transport. For further investigation of
convective mass transport in freezing processes, the Grashof number
should be evaluated at increasing additive concentrations, requiring
the determination of freeze concentration at the freezing front.
A coupling of diffusive models and computational fluid dynamics
might add to the process understanding of mass transport effects.
4 | CONCLUSION
In this study, Raman resonance spectroscopy was thoroughly investigated
as a novel approach for process monitoring of pharmaceutical freezing
processes. While the previous characterization of freeze concentration
was limited on the frozen bulk, Raman spectroscopy gives a deeper
process understanding of the origin freeze concentration profiles in fro-
zen bulk volumes. Current low‐resolution frozen sampling might under-
estimate freeze concentration by many‐fold, as convective flows were in
dimensions of 1mm or thinner. This highlights the importance of spatial
high‐resolved data acquired by Raman spectroscopy. The qualitative
evaluations of diffusional and convectional mass fluxes are a powerful
tool for the optimization of freezing processes with regard to process
parameters such as temperature and formulation composition. Further
information could be retrieved by using an external Raman probe with a
long‐distance focal length scanning for freeze concentration. This study
contributes to quality‐by‐design freezing processes and formulation de-
velopment. Product loss due to transient freeze concentration effects can
be identified and reduced. The method provides the first real‐time data of
freezing processes for the validation of scale‐down models as well as
simulations. Process characterization by Raman monitoring provides
proven acceptable and normal ranges for regulatory authorities.
F IGURE 9 Freeze concentration predictions for monoclonal antibody (mAb), Tris, and sucrose in formulations with varying amounts of
sucrose from 100 to 300mM. The Raman probe was positioned 5mm above ground.
F IGURE 10 Final freeze concentration slope of sucrose and
monoclonal antibody (mAb) before freezing as a function of sucrose
concentration. The dashed line represents a linear regression of the
sucrose slopes. The density of the formulating buffers is proportional
to the sucrose concentration and denoted in parentheses
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